We have received great response to my original post for initiating discussions on utility of current in silico and in vitro tools that can be repurposed for addressing preclinical development related questions on safety and toxicity due to drug product exposure.
We will kick off a meeting soon
Thanks to those who have expressed interest and also provided your email contacts to join this working group.
------------------------------
Vibha Jawa
Chief Scientific Officer
Epivax
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------